Comparative responses to endothelin-2 and sarafotoxin 6b in the pulmonary vascular bed of the cat

Can J Physiol Pharmacol. 1991 Feb;69(2):211-4. doi: 10.1139/y91-031.

Abstract

Pulmonary vascular responses to endothelin-2 and sarafotoxin 6b were investigated in the feline pulmonary vascular bed under natural flow and constant flow conditions. Injections of endothelin-2 and sarafotoxin 6b in a dose of 0.3 nmol/kg iv increased pulmonary arterial and left atrial pressures and cardiac output, and caused a biphasic change in calculated pulmonary vascular resistance. Endothelin-2 caused a biphasic change in systemic arterial pressure, while sarafotoxin 6b only decreased arterial pressure. Under constant flow conditions in the intact-chest cat, injections of endothelin-2 and sarafotoxin 6b in doses of 0.1-1 nmol into the perfused lobar artery increased lobar arterial pressure in a dose-related manner but were less potent than the thromboxane A2 mimic, U46619. An ET analog with only the Cys1-Cys15 disulfide bond and an amidated carboxy terminus had no significant activity in the pulmonary vascular bed. The present data show that endothelin-2 and sarafotoxin 6b have significant vasoconstrictor activity in the pulmonary vascular bed of the cat.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Anesthesia
  • Animals
  • Blood Pressure / drug effects
  • Cardiac Output / drug effects
  • Cats
  • Dose-Response Relationship, Drug
  • Endothelins / pharmacology*
  • Female
  • Male
  • Prostaglandin Endoperoxides, Synthetic / pharmacology
  • Pulmonary Circulation / drug effects*
  • Vascular Resistance / drug effects
  • Vasoconstrictor Agents / pharmacology*
  • Viper Venoms / pharmacology*

Substances

  • Endothelins
  • Prostaglandin Endoperoxides, Synthetic
  • Vasoconstrictor Agents
  • Viper Venoms
  • sarafotoxins s6
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid